Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,350,000
$150.41 P/Share
|
|
Feb 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$750,000
$150.41 P/Share
|
|
Feb 24
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
1,753,697
-1.8%
|
$257,793,459
$147.11 P/Share
|
|
Feb 23
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.07%
|
$2,160,000
$144.09 P/Share
|
|
Feb 23
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 23
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
2,947,638
-1.14%
|
$424,459,872
$144.01 P/Share
|
|
Feb 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-37.61%
|
$820,000
$164.98 P/Share
|
|
Feb 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 22
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$830,000
$166.63 P/Share
|
|
Feb 22
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 22
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
1,836,766
-0.82%
|
$301,229,624
$164.7 P/Share
|
|
Feb 19
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.86%
|
$1,933,050
$175.37 P/Share
|
|
Feb 18
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,710,000
$171.8 P/Share
|
|
Feb 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,566,000
$174.28 P/Share
|
|
Feb 16
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$910,000
$182.8 P/Share
|
|
Feb 16
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 16
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.92%
|
$2,730,000
$182.8 P/Share
|
|
Feb 16
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 12
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.07%
|
$1,999,326
$181.29 P/Share
|
|
Feb 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$925,000
$185.0 P/Share
|
|
Feb 11
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,780,000
$178.29 P/Share
|
|
Feb 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,638,000
$182.74 P/Share
|
|
Feb 08
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$880,000
$176.98 P/Share
|
|
Feb 08
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 08
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,670
-31.28%
|
$667,940
$182.71 P/Share
|
|
Feb 08
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,670
+50.0%
|
$44,040
$12.21 P/Share
|
|
Feb 05
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.0%
|
$1,922,004
$174.12 P/Share
|
|
Feb 04
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,660,000
$166.42 P/Share
|
|
Feb 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Feb 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,404,000
$156.51 P/Share
|
|
Feb 03
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.61%
|
$1,560,000
$156.51 P/Share
|
|
Feb 03
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 02
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.61%
|
$1,580,000
$158.4 P/Share
|
|
Feb 02
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-29.26%
|
$815,000
$163.67 P/Share
|
|
Feb 01
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Feb 01
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$860,000
$172.99 P/Share
|
|
Feb 01
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 29
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.41%
|
$1,933,050
$175.12 P/Share
|
|
Jan 28
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,540,000
$154.11 P/Share
|
|
Jan 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Jan 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,359,000
$151.27 P/Share
|
|
Jan 25
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$690,000
$138.77 P/Share
|
|
Jan 25
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jan 25
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.15%
|
$2,840,000
$142.97 P/Share
|
|
Jan 25
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.6%
|
$0
$0.99 P/Share
|
|
Jan 25
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-35.95%
|
$710,000
$142.51 P/Share
|